Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (The Hill) — Drugmaker Boehringer Ingelheim ...
(The Hill) — Drugmaker Boehringer Ingelheim plans to cap the out-of-pocket costs for all its inhalers at $35 a month after coming under fire from Democratic lawmakers over pricing. The company on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback